Rapport Therapeutics (RAPP) Insider Trading & Ownership

Rapport Therapeutics logo
$24.82 -1.33 (-5.09%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$24.80 -0.02 (-0.06%)
As of 11/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rapport Therapeutics (NASDAQ:RAPP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.48%
Number Of
Insiders Buying
(Last 12 Months)
7
Amount Of
Insider Buying
(Last 12 Months)
$22.02M
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$42.88M
Get RAPP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rapport Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RAPP Insider Buying and Selling by Quarter

Rapport Therapeutics Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/28/2026
James Healy
Director
Buy969,480$21.00$20,359,080.00  
10/23/2026
Ramiro Sanchez
Director
Buy3,600$27.35$98,460.00  
10/22/2026
John Maraganore
Director
Buy9,411$26.45$248,920.95  
10/22/2026
Paul M Silva
Director
Buy3,680$27.07$99,617.60  
10/22/2026
Steven M Paul
Director
Buy35,714$27.28$974,277.92  
10/22/2026Buy3,789$26.39$99,991.71  
10/21/2026Sell2,210$29.16$64,443.60  
10/21/2026Buy5,500$26.10$143,550.00  
10/7/2026Sell1,147$30.66$35,167.02  
10/6/2026Sell3,375$32.03$108,101.25  
9/30/2026Sell10,000$33.19$331,900.00  
9/23/2026Sell2,210$39.17$86,565.70  
9/8/2026Sell8,210$45.61$374,458.10  
8/25/2026Sell18,921$49.57$937,913.97  
8/19/2026Sell404$49.90$20,159.60  
8/11/2026Sell28,958$48.01$1,390,273.58  
8/10/2026Sell22,541$46.26$1,042,746.66  
7/27/2026Sell2,210$42.11$93,063.10  
5/26/2026
Rock Ventures V L.P. Third
Major Shareholder
Sell18,572$40.05$743,808.60  
5/11/2026
Rock Ventures V L.P. Third
Major Shareholder
Sell133,618$40.24$5,376,788.32  
5/8/2026
Rock Ventures V L.P. Third
Major Shareholder
Sell5,018$40.31$202,275.58  
5/7/2026
Rock Ventures V L.P. Third
Major Shareholder
Sell271,495$40.12$10,892,379.40  
4/17/2026Sell20,225$39.99$808,797.75  
4/17/2026
Rock Ventures V L.P. Third
Major Shareholder
Sell426,005$40.32$17,176,521.60  
4/14/2026Sell10,200$35.08$357,816.00  
4/13/2026Sell9,165$34.97$320,500.05  
4/10/2026Sell500$34.98$17,490.00  
4/8/2026Sell360$34.90$12,564.00  
3/5/2026Sell2,014$28.93$58,265.02  
2/18/2026Sell5,833$29.34$171,140.22  
2/18/2026Sell5,083$29.36$149,236.88  
2/17/2026Sell8,500$29.02$246,670.00  
1/20/2026Sell5,833$26.12$152,357.96  
1/20/2026Sell5,083$26.11$132,717.13  
1/15/2026Sell8,500$26.84$228,140.00  
12/31/2025Sell6,567$30.05$197,338.35  
12/31/2025Sell2,840$30.05$85,342.00  
12/17/2025Sell5,833$29.64$172,890.12  
12/17/2025Sell5,083$29.63$150,609.29  
12/15/2025Sell8,500$30.02$255,170.00  
Your free book is about to disappear (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
11/17/2025Sell5,833$25.19$146,933.27  
11/17/2025Sell5,083$25.20$128,091.60  
11/17/2025Sell8,500$25.19$214,115.00  
(Data available from 1/1/2013 forward)

RAPP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Rapport Therapeutics includes Abraham Ceesay, Cheryl Gault, David Bredt, James Healy, John Maraganore, Krishnaswamy Yeleswaram, Paul M Silva, Ramiro Sanchez, Rock Ventures V L.P. Third, Steven M Paul, Troy A Ignelzi, and Wendy B Young. Learn more on insiders at RAPP.

12.48% of Rapport Therapeutics stock is owned by insiders. Learn more on RAPP's insider holdings.

The following insiders have purchased RAPP shares in the last 24 months: James Healy ($20,359,080.00), John Maraganore ($248,920.95), Paul M Silva ($99,617.60), Ramiro Sanchez ($98,460.00), Steven M Paul ($974,277.92), Troy A Ignelzi ($243,540.00), and Wendy B Young ($240,351.71).

Insiders have purchased a total of 1,050,574 RAPP shares in the last 24 months for a total of $22,264,248.18 bought.

The following insiders have sold RAPP shares in the last 24 months: Abraham Ceesay ($7,629,825.81), Cheryl Gault ($581,815.02), David Bredt ($1,726,148.35), Krishnaswamy Yeleswaram ($1,622,669.40), and Rock Ventures V L.P. Third ($34,391,773.50).

Insiders have sold a total of 1,210,765 Rapport Therapeutics shares in the last 24 months for a total of $45,952,232.08 sold.



Insider trading data for NASDAQ:RAPP was last updated on 10/28/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners